Compare DERM & BMHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DERM | BMHL |
|---|---|---|
| Founded | 2014 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 190.3M | 152.9M |
| IPO Year | 2021 | 2024 |
| Metric | DERM | BMHL |
|---|---|---|
| Price | $4.98 | $3.07 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $13.75 | N/A |
| AVG Volume (30 Days) | ★ 178.1K | 5.3K |
| Earning Date | 11-11-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.72 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $61,858,000.00 | N/A |
| Revenue This Year | $25.29 | N/A |
| Revenue Next Year | $50.00 | N/A |
| P/E Ratio | ★ N/A | $66.66 |
| Revenue Growth | ★ 10.20 | N/A |
| 52 Week Low | $4.31 | $3.00 |
| 52 Week High | $9.56 | $6.35 |
| Indicator | DERM | BMHL |
|---|---|---|
| Relative Strength Index (RSI) | 34.52 | 29.84 |
| Support Level | $4.84 | $3.22 |
| Resistance Level | $5.50 | $3.87 |
| Average True Range (ATR) | 0.34 | 0.40 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 15.91 | 16.32 |
Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.
Bluemount Holdings Ltd through its operating subsidiaries, is a Hong Kong-based consulting and advisory, financial services, and luxury timepiece trading provider. The Company provides consulting and advisory services on business development strategies, including seeking suitable transaction projects for business development or diversification and suitable business partners or investors for fund-raising projects. Its services are centered around three core offerings: Business Transformation, Strategy, and Transactions. The Company also sources, buys, and sells brand-new luxury branded timepieces. It operates through two reportable segments: security-related services and asset management, and trading of timepieces, with the trading of timepieces generating maximum revenue.